$ Value
$0
Shares
97,256
Price
$0
Filed
Mar 3
Insider
Name
Donley Matthew Maxwell
Title
Chief Operating Officer
CIK
0001636642
Roles
Transaction Details
Transaction Date
2026-02-27
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
97,256
Footnotes
Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement. | Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. | One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter.
Filing Info
Donley Matthew Maxwell's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-02 | AUPH | F | $579K |
| 2026-02-27 | AUPH | A | $0 |
| 2026-02-27 | AUPH | A | $0 |
| 2026-02-20 | AUPH | F | $474K |
| 2026-01-02 | AUPH | A | $0 |
| 2026-01-02 | AUPH | F | $682K |
Other Insiders at AUPH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| TANG KEVIN | $12.7M | — | 2026-03-03 |
|
Greenleaf Peter
Chief Executive Officer
|
— | — | 2026-03-02 |
|
Donley Matthew Maxwell
Chief Operating Officer
|
— | — | 2026-03-02 |
|
Miller Joseph M
Chief Financial Officer
|
— | — | 2026-03-02 |
|
Robertson Stephen P.
EVP, General Counsel
|
— | — | 2026-03-02 |
|
Keenan Greg
SVP, Chief Medical Officer
|
— | — | 2026-03-06 |